Christopher A. French
- Molecular Biology top 1%
- Hematology top 0.2%
- Oncology top 1%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Jonathan A. FletcherJon C. AsterAntonio R. Pérez‐AtaydeI MiyoshiMichael J. CameronEdward B. StelowIchiro KubonishiJeffery L. Kutok
- Topics
- Protein Degradation and Inhibitors (81 papers)Ubiquitin and proteasome pathways (62 papers)Multiple Myeloma Research and Treatments (46 papers)
- Cited by
- HematologyMolecular BiologyOncology
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyGenes & Development
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Christopher A. French
108 papers receiving 6.6k citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 5.1k
- Hematology 2.4k
- Oncology 1.7k
- Surgery 835
- Pulmonary and Respiratory Medicine 681
Countries citing papers authored by Christopher A. French
This map shows the geographic impact of Christopher A. French's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. French with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. French more than expected).
Fields of papers citing papers by Christopher A. French
This network shows the impact of papers produced by Christopher A. French. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. French. The network helps show where Christopher A. French may publish in the future.
Co-authorship network of co-authors of Christopher A. French
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. French. A scholar is included among the top collaborators of Christopher A. French based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. French. Christopher A. French is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 11 | |
| 6 | 1 | |
| 7 | 6 | |
| 8 | 6 | |
| 9 | 13 | |
| 10 | 58 | |
| 11 | 1 | |
| 12 | 131 | |
| 13 | 39 | |
| 14 | 268 | |
| 15 | 186 | |
| 16 | 45 | |
| 17 | 276 | |
| 18 | 156 | |
| 19 | 142 | |
| 20 | BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. | 380 |
About Christopher A. French
Christopher A. French is a scholar working on Hematology, Molecular Biology and Oncology, having authored 109 papers that have together received 6.7k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (81 papers), Ubiquitin and proteasome pathways (62 papers) and Multiple Myeloma Research and Treatments (46 papers). The work is most often cited by research in Hematology (2.4k citations), Molecular Biology (5.1k citations) and Oncology (1.7k citations). Christopher A. French has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Jonathan A. Fletcher, Jon C. Aster, Antonio R. Pérez‐Atayde, I Miyoshi, Michael J. Cameron, Edward B. Stelow, Ichiro Kubonishi, Jeffery L. Kutok, Holcombe E. Grier and Sara O. Vargas. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.